Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009.
Héritier S, Le Merrer M, Jaubert F, Bigorre M, Gillibert-Yvert M, de Courtivron B, Ziade M, Bertrand Y, Carrie C, Chastagner P, Bost-Bru C, Léonard JC, Ouache M, Boccon-Gibod L, Mary P, de Blic J, Pin I, Wendling D, Revillon Y, Houdoin V, Forin V, Lepointe HD, Languepin J, Wagnon J, Epaud R, Fauroux B, Donadieu J. Héritier S, et al. Orphanet J Rare Dis. 2010 Feb 3;5:3. doi: 10.1186/1750-1172-5-3. Orphanet J Rare Dis. 2010. PMID: 20128925 Free PMC article.
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age.
Rigaud C, Barkaoui MA, Thomas C, Bertrand Y, Lambilliotte A, Miron J, Aladjidi N, Plat G, Jeziorski E, Galambrun C, Mansuy L, Lutz P, Deville A, Armari-Alla C, Reguerre Y, Fraitag S, Coulomb A, Gandemer V, Leboulanger N, Moshous D, Hoang-Xuan K, Tazi A, Heritier S, Emile JF, Donadieu J. Rigaud C, et al. Among authors: heritier s. Br J Haematol. 2016 Sep;174(6):887-98. doi: 10.1111/bjh.14140. Epub 2016 Jun 7. Br J Haematol. 2016. PMID: 27273725 Free article.
BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.
Héritier S, Emile JF, Barkaoui MA, Thomas C, Fraitag S, Boudjemaa S, Renaud F, Moreau A, Peuchmaur M, Chassagne-Clément C, Dijoud F, Rigau V, Moshous D, Lambilliotte A, Mazingue F, Kebaili K, Miron J, Jeziorski E, Plat G, Aladjidi N, Ferster A, Pacquement H, Galambrun C, Brugières L, Leverger G, Mansuy L, Paillard C, Deville A, Armari-Alla C, Lutun A, Gillibert-Yvert M, Stephan JL, Cohen-Aubart F, Haroche J, Pellier I, Millot F, Lescoeur B, Gandemer V, Bodemer C, Lacave R, Hélias-Rodzewicz Z, Taly V, Geissmann F, Donadieu J. Héritier S, et al. J Clin Oncol. 2016 Sep 1;34(25):3023-30. doi: 10.1200/JCO.2015.65.9508. Epub 2016 Jul 5. J Clin Oncol. 2016. PMID: 27382093 Free PMC article.
[Child Langerhans cell histiocytosis].
Donadieu J, Héritier S. Donadieu J, et al. Among authors: heritier s. Presse Med. 2017 Jan;46(1):85-95. doi: 10.1016/j.lpm.2016.09.013. Epub 2017 Jan 10. Presse Med. 2017. PMID: 28087208 Review. French.
Circulating cell-free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis.
Héritier S, Hélias-Rodzewicz Z, Lapillonne H, Terrones N, Garrigou S, Normand C, Barkaoui MA, Miron J, Plat G, Aladjidi N, Pagnier A, Deville A, Gillibert-Yvert M, Moshous D, Lefèvre-Utile A, Lutun A, Paillard C, Thomas C, Jeziorski E, Nizard P, Taly V, Emile JF, Donadieu J. Héritier S, et al. Br J Haematol. 2017 Aug;178(3):457-467. doi: 10.1111/bjh.14695. Epub 2017 Apr 25. Br J Haematol. 2017. PMID: 28444728 Free article.
Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.
Héritier S, Barkaoui MA, Miron J, Thomas C, Moshous D, Lambilliotte A, Mazingue F, Kebaili K, Jeziorski E, Plat G, Aladjidi N, Pacquement H, Galambrun C, Brugières L, Leverger G, Mansuy L, Paillard C, Deville A, Pagnier A, Lutun A, Gillibert-Yvert M, Stephan JL, Cohen-Aubart F, Haroche J, Pellier I, Millot F, Gandemer V, Martin-Duverneuil N, Taly V, Hélias-Rodzewicz Z, Emile JF, Hoang-Xuan K, Idbaih A, Donadieu J. Héritier S, et al. Br J Haematol. 2018 Nov;183(4):608-617. doi: 10.1111/bjh.15577. Epub 2018 Nov 12. Br J Haematol. 2018. PMID: 30421536 Free article. Clinical Trial.
Long-term follow-up of children with risk organ-negative Langerhans cell histiocytosis after 2-chlorodeoxyadenosine treatment.
Barkaoui MA, Queheille E, Aladjidi N, Plat G, Jeziorski E, Moshous D, Lambilliotte A, Kebaili K, Pacquement H, Leverger G, Mansuy L, Entz-Werlé N, Bodet D, Schneider P, Pagnier A, Lutun A, Gillibert-Yvert M, Millot F, Toutain F, Reguerre Y, Thomas C, Tazi A, Emile JF, Donadieu J, Héritier S. Barkaoui MA, et al. Among authors: heritier s. Br J Haematol. 2020 Dec;191(5):825-834. doi: 10.1111/bjh.16944. Epub 2020 Jul 22. Br J Haematol. 2020. PMID: 32700439 Free article. Clinical Trial.
Chest computed tomography findings for a cohort of children with pulmonary Langerhans cell histiocytosis.
Della Valle V, Donadieu J, Sileo C, Barkaoui MA, Héritier S, Brisse H, Boutry N, Tréguier C, Chateil JF, Petit P, Pracros JP, Chastagner P, Boyer C, Veillon F, Durand C, Mounayer C, Kambouchner M, Brauner M, Tazi A, Epaud R, Ducou le Pointe H. Della Valle V, et al. Among authors: heritier s. Pediatr Blood Cancer. 2020 Oct;67(10):e28496. doi: 10.1002/pbc.28496. Epub 2020 Jul 25. Pediatr Blood Cancer. 2020. PMID: 32710685
201 results